Germany, May 12 -- Evonik will apply a price increase of up to 15 percent on selected products within the Rexim(R) pharmaceutical amino and keto acid portfolio. The price increase is a response to rising energy, raw material and freight expenses. It will be effective immediately for all markets.All existing contracts and supply agreements will be honored.
Published by HT Digital Content Services with permission from Pivotal Sources....